# Active Pharmacovigilance of Anti-cancer Medicines

> **NCT05825794** · — · UNKNOWN · sponsor: **IRCCS Burlo Garofolo** · enrollment: 50 (estimated)

## Conditions studied

- Oncology
- Drugs
- Pharmacovigilance

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT05825794
- **Lead sponsor:** IRCCS Burlo Garofolo
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-10-28
- **Primary completion:** 2023-12-31
- **Final completion:** 2023-12-31
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2023-04-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05825794

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05825794, "Active Pharmacovigilance of Anti-cancer Medicines". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05825794. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*